Correlation Between DexCom and Perspective Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Perspective Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Perspective Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Perspective Therapeutics, you can compare the effects of market volatilities on DexCom and Perspective Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Perspective Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Perspective Therapeutics.

Diversification Opportunities for DexCom and Perspective Therapeutics

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between DexCom and Perspective is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Perspective Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perspective Therapeutics and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Perspective Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perspective Therapeutics has no effect on the direction of DexCom i.e., DexCom and Perspective Therapeutics go up and down completely randomly.

Pair Corralation between DexCom and Perspective Therapeutics

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.59 times more return on investment than Perspective Therapeutics. However, DexCom Inc is 1.68 times less risky than Perspective Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Perspective Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  11,671  in DexCom Inc on September 2, 2024 and sell it today you would lose (3,872) from holding DexCom Inc or give up 33.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Perspective Therapeutics

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Perspective Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Perspective Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

DexCom and Perspective Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Perspective Therapeutics

The main advantage of trading using opposite DexCom and Perspective Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Perspective Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perspective Therapeutics will offset losses from the drop in Perspective Therapeutics' long position.
The idea behind DexCom Inc and Perspective Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated